Sendur, M. A. N. Et Al. 2015. The efficacy and predictive factors of response of second line triplet (modified-EOX; epirubicin-oxaliplatin-capacitabine) regimen in metastatic gastric cancer. European Cancer Congress , (Vienna, Austria).

Sendur, M. A. N., Ozdemir, N., Aksoy, S., Yazici, O., Yazilitas, D., Akinci, M. B., ... Dede, D. S.(2015). The efficacy and predictive factors of response of second line triplet (modified-EOX; epirubicin-oxaliplatin-capacitabine) regimen in metastatic gastric cancer . European Cancer Congress, Vienna, Austria

Sendur, M. Et Al. "The efficacy and predictive factors of response of second line triplet (modified-EOX; epirubicin-oxaliplatin-capacitabine) regimen in metastatic gastric cancer," European Cancer Congress, Vienna, Austria, 2015

Sendur, M. A. Et Al. "The efficacy and predictive factors of response of second line triplet (modified-EOX; epirubicin-oxaliplatin-capacitabine) regimen in metastatic gastric cancer." European Cancer Congress , Vienna, Austria, 2015

Sendur, M. A. N. Et Al. (2015) . "The efficacy and predictive factors of response of second line triplet (modified-EOX; epirubicin-oxaliplatin-capacitabine) regimen in metastatic gastric cancer." European Cancer Congress , Vienna, Austria.

@conferencepaper{conferencepaper, author={M. A. N. Sendur Et Al. }, title={The efficacy and predictive factors of response of second line triplet (modified-EOX; epirubicin-oxaliplatin-capacitabine) regimen in metastatic gastric cancer}, congress name={European Cancer Congress}, city={Vienna}, country={Austria}, year={2015}}